Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2009-1-7
pubmed:abstractText
Paracetamol (acetaminophen) is one of the most widely used drugs for analgesia. We aimed to investigate the use of a ready-to-use intravenous (i.v.) paracetamol 1 g solution (Perfalgan) as monotherapy or as adjunct therapy in patients undergoing elective ambulatory surgery.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1742-1241
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
63
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
112-20
pubmed:meshHeading
pubmed-meshheading:19125998-Acetaminophen, pubmed-meshheading:19125998-Adolescent, pubmed-meshheading:19125998-Adult, pubmed-meshheading:19125998-Aged, pubmed-meshheading:19125998-Aged, 80 and over, pubmed-meshheading:19125998-Ambulatory Surgical Procedures, pubmed-meshheading:19125998-Analgesics, pubmed-meshheading:19125998-Drug Therapy, Combination, pubmed-meshheading:19125998-Evidence-Based Medicine, pubmed-meshheading:19125998-Female, pubmed-meshheading:19125998-Humans, pubmed-meshheading:19125998-Infusions, Intravenous, pubmed-meshheading:19125998-Male, pubmed-meshheading:19125998-Middle Aged, pubmed-meshheading:19125998-Pain, Postoperative, pubmed-meshheading:19125998-Pain Measurement, pubmed-meshheading:19125998-Patient Satisfaction, pubmed-meshheading:19125998-Prospective Studies, pubmed-meshheading:19125998-Treatment Outcome, pubmed-meshheading:19125998-Young Adult
pubmed:year
2009
pubmed:articleTitle
Efficacy and tolerability of ready-to-use intravenous paracetamol solution as monotherapy or as an adjunct analgesic therapy for postoperative pain in patients undergoing elective ambulatory surgery: open, prospective study.
pubmed:affiliation
Medical Department, Bristol-Myers Squibb GmbH & Co. KGaA, Munich, Germany. terez.spevaknegoeroecs@bms.com
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study